Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Oncomed Pharma (OMED)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2013	12-2012	12-2011	12-2010
Assets
Current Assets
Cash & Cash Equivalents	208,931	16,263	11,785	N/A
Marketable Securities	107,263	49,976	88,625	N/A
Receivables	23	4,023	N/A	N/A
TOTAL	$318,744	$71,385	$100,996	$N/A

Non-Current Assets
PPE Net	4,641	5,462	6,154	N/A
Other Non-Current Assets	10,300	2,921	55	0
TOTAL	$14,941	$8,383	$6,209	$N/A

Total Assets	$333,685	$79,768	$107,205	$N/A

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	5,706	849	3,412	0
Accrued Expenses	9,860	3,798	4,420	N/A
Other current liabilities	10	196	216	N/A
TOTAL	$62,017	$20,129	$18,900	$N/A

Non-Current Liabilities
Deferred Revenues	35,683	15,286	10,506	N/A
Other Non-Current Liabilities	1,529	23	4	0
TOTAL	$153,546	$21,093	$28,466	$N/A

Total Liabilities	$215,563	$41,222	$47,366	$N/A

Shareholders' Equity
Shares Outstanding, K	29,480	27,065	N/A	N/A
Common Shares	29	6	1	N/A
Retained earnings	-174,426	-148,355	-126,120	N/A
Other shareholders' equity	14	182,788	182,822	0
TOTAL	$118,122	$38,546	$59,839	$N/A

Total Liabilities And Equity	$333,685	$79,768	$107,205	$0